| 000 | 00940 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517145407.0 | ||
| 264 | 0 | _c20180914 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1474-4457 | ||
| 024 | 7 |
_a10.1016/S1473-3099(17)30165-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilder-Smith, Annelies | |
| 245 | 0 | 0 |
_aMoving forward with Takeda's live chimeric tetravalent dengue vaccine. _h[electronic resource] |
| 260 |
_bThe Lancet. Infectious diseases _c06 2017 |
||
| 300 |
_a566-568 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aAntibodies, Viral |
| 650 | 0 | 4 | _aDengue |
| 650 | 0 | 4 | _aDengue Vaccines |
| 650 | 0 | 4 |
_aDengue Virus _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aVaccines, Attenuated |
| 773 | 0 |
_tThe Lancet. Infectious diseases _gvol. 17 _gno. 6 _gp. 566-568 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1473-3099(17)30165-2 _zAvailable from publisher's website |
| 999 |
_c27037833 _d27037833 |
||